We previously demonstrated that administration of apolipoprotein A-I (apoA-I), either independently (lipid free) or as part of a reconstituted HDL with (rHDL) containing PLPC protects against liver inflammation and improves insulin resistance in high-fat fed C57Bl/6 mice [2]. Here, APOA1 is linked to inflammation.